Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Brenton L. SaundersCEO & Chairman | -2,89k | 45,95k | Sale to Issuer | 15,92 | 425,67k | -0,67% |
| 2026-05-22 | Mr. Brenton L. SaundersCEO & Chairman | 4,45k | 70,80k | Derivative Exercise and Retained Stock | 15,92 | 425,67k | 1,06% |
| 2026-05-19 | Ms. Karen L. LingIndependent Director | 20,34k | 329,48k | Derivative Exercise and Retained Stock | 16,20 | 41,68k | 95,31% |
| 2026-05-05 | Mr. Osama A. EldessoukyExec. VP & CFO | 61,06k | 976,99k | Derivative Exercise and Retained Stock | 16,00 | 201,00k | 43,64% |
| 2026-05-05 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 21,06k | 336,93k | Derivative Exercise and Retained Stock | 16,00 | 107,52k | 24,35% |
| 2026-05-05 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 13,55k | 216,78k | Derivative Exercise and Retained Stock | 16,00 | 52,94k | 34,40% |
| 2026-05-05 | Mr. Luc BonnefoyPresident of Surgical | 9,25k | 148,03k | Derivative Exercise and Retained Stock | 16,00 | 34,66k | 36,41% |
| 2026-05-05 | Mr. Thomas J. AppioInsider | 27,58k | 441,33k | Derivative Exercise and Retained Stock | 16,00 | 27,58k | - |
| 2026-05-05 | Mr. Osama A. EldessoukyExec. VP & CFO | -63,94k | 1,02M | Sale to Issuer | 16,00 | 343,19k | -15,70% |
| 2026-05-05 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -13,66k | 218,62k | Sale to Issuer | 16,00 | 166,38k | -7,59% |
| 2026-05-05 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -8,67k | 138,77k | Sale to Issuer | 16,00 | 89,64k | -8,82% |
| 2026-05-05 | Mr. Luc BonnefoyPresident of Surgical | -11,97k | 191,52k | Sale to Issuer | 16,00 | 88,03k | -11,97% |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4,22k | 66,70k | Sale to Issuer | 15,82 | 32,52k | -11,48% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -15,81k | 250,05k | Sale to Issuer | 15,82 | 125,30k | -11,20% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 24,36k | 385,39k | Derivative Exercise and Retained Stock | 15,82 | 125,30k | 24,13% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -15,81k | 0,00 | Derivative Exercise and Sale | 15,82 | 125,30k | - |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | 11,05k | 174,81k | Derivative Exercise and Retained Stock | 15,82 | 32,51k | 51,48% |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4,22k | 66,70k | Verkauf | 15,82 | 32,51k | -11,48% |
| 2026-03-06 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 14,60k | 250,33k | Kauf | 17,15 | 100,94k | 16,91% |
| 2026-03-06 | Mr. Osama A. EldessoukyExec. VP & CFO | 4,00k | 68,52k | Kauf | 17,13 | 139,94k | 2,94% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 14,70k | 251,96k | Kauf | 17,14 | 421,22k | 3,62% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 727,00 | 12,46k | Kauf | 17,10 - 17,16 | 421,22k | 0,17% |
| 2026-03-06 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 14,60k | 250,34k | Kauf | 17,10 - 17,20 | 100,94k | 16,91% |
| 2026-03-06 | Mr. Osama A. EldessoukyExec. VP & CFO | 4,00k | 68,52k | Kauf | 17,13 | 139,94k | 2,94% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 18,79k | 311,04k | Kauf | 12,55 - 17,19 | 421,22k | 4,67% |
| 2026-03-03 | Mr. Thomas Warren RossLead Independent Director | 4,50k | 79,56k | Kauf | 17,68 | 44,55k | 11,24% |
| 2026-03-03 | Mr. Thomas Warren RossLead Independent Director | 950,00 | 16,79k | Kauf | 17,67 | 17,00k | 5,92% |
| 2026-03-02 | Dr. Eduardo C. AlfonsoIndependent Director | 4,30k | 76,97k | Kauf | 17,90 | 4,30k | - |
| 2026-02-27 | Dr. Andrew C. von EschenbachIndependent Director | 4,36k | 79,88k | Kauf | 18,31 | 46,11k | 10,45% |
| 2026-02-27 | Mr. Osama A. EldessoukyExec. VP & CFO | 113,10k | 2,07M | Derivative Exercise and Retained Stock | 18,30 | 135,94k | 495,14% |
| 2026-02-27 | Mr. Osama A. EldessoukyExec. VP & CFO | -51,47k | 941,90k | Verkauf | 18,30 | 135,94k | -27,46% |
| 2026-02-27 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 47,12k | 862,31k | Derivative Exercise and Retained Stock | 18,30 | 86,47k | 119,77% |
| 2026-02-27 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -11,62k | 212,66k | Verkauf | 18,30 | 86,47k | -11,85% |
| 2026-02-27 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 20,03k | 366,49k | Derivative Exercise and Retained Stock | 18,30 | 39,39k | 103,43% |
| 2026-02-27 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -5,69k | 104,16k | Verkauf | 18,30 | 39,39k | -12,63% |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | 16,35k | 299,17k | Derivative Exercise and Retained Stock | 18,30 | 25,41k | 180,40% |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | -9,22k | 168,74k | Verkauf | 18,30 | 25,41k | -26,63% |
| 2026-02-27 | Dr. Andrew C. von EschenbachIndependent Director | 4,36k | 79,88k | Kauf | 18,31 | 18,56k | 30,74% |
| 2026-03-02 | Dr. Eduardo C. AlfonsoIndependent Director | 4,30k | 76,97k | Kauf | 17,90 | 4,30k | - |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -10,17k | 186,52k | Sale to Issuer | 18,30 - 18,49 | 39,08k | -20,65% |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4,99k | 91,90k | Sale to Issuer | 18,30 - 18,49 | 25,68k | -16,27% |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -17,94k | 329,07k | Sale to Issuer | 18,30 - 18,49 | 28,24k | -38,85% |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -18,87k | 345,64k | Sale to Issuer | 18,30 - 18,49 | 68,16k | -21,68% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | 575,90k | 10,59M | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 406,52k | -340,00% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | -373,66k | 984,20 | Derivative Exercise and Sale | 18,30 - 18,49 | 406,52k | - |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 18,84k | 346,75k | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 86,34k | 27,92% |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -5,86k | 0,00 | Derivative Exercise and Sale | 18,30 - 18,49 | 86,34k | - |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | 167,00k | 3,07M | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 74,31k | -180,17% |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | -121,71k | 14,82 | Derivative Exercise and Sale | 18,30 - 18,49 | 74,31k | - |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 82,80k | 1,52M | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 50,97k | -260,09% |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -38,70k | 58,90 | Derivative Exercise and Sale | 18,30 - 18,49 | 50,97k | - |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 51,91k | 954,55k | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 25,05k | -193,28% |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -23,77k | 504,64 | Derivative Exercise and Sale | 18,30 - 18,49 | 25,05k | - |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | 67,27k | 1,24M | Derivative Exercise and Retained Stock | 18,30 - 18,49 | 25,68k | -161,74% |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -39,93k | 371,26 | Derivative Exercise and Sale | 18,30 - 18,49 | 25,68k | - |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | 5,59k | 102,35k | Derivative Exercise and Retained Stock | 18,30 | 18,28k | 44,07% |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -19,71k | 44,32k | Derivative Exercise and Sale | 18,30 - 18,49 | 18,28k | - |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -1,06k | 19,18k | Verkauf | 18,30 - 18,49 | 18,28k | -5,48% |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -5,86k | 107,81k | Sale to Issuer | 18,30 - 18,49 | 86,34k | -6,35% |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | -74,04k | 1,36M | Sale to Issuer | 18,30 - 18,49 | 133,67k | -35,65% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | -46,71k | 858,95k | Sale to Issuer | 18,30 - 18,49 | 406,52k | -10,31% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | -65,44k | 1,18M | Sale to Issuer | 17,99 | 334,53k | -16,36% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | 122,06k | 0,00 | Derivative Exercise and Retained Stock | - | 334,53k | 57,44% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | -65,44k | 1,18M | Derivative Exercise and Sale | 17,99 | 334,53k | - |
| 2026-02-23 | Mr. Steven H. CollisIndependent Director | 15,00k | 267,15k | Kauf | 17,81 | 15,00k | - |
| 2026-02-20 | Mr. Russel C. RobertsonIndependent Director | 4,40k | 78,76k | Kauf | 17,90 | 10,21k | 75,76% |
| 2026-02-23 | Mr. Steven H. CollisIndependent Director | 15,00k | 267,15k | Kauf | 17,81 | 15,00k | - |
| 2026-02-20 | Mr. Russel C. RobertsonIndependent Director | 4,40k | 78,76k | Kauf | 17,90 | 10,21k | 75,76% |
| 2026-02-19 | Ms. Karen L. LingIndependent Director | 4,00k | 70,97k | Kauf | 17,74 | 21,34k | 23,07% |
| 2026-02-19 | Ms. Karen L. LingIndependent Director | 4,00k | 70,97k | Kauf | 17,74 | 21,34k | 23,07% |
| 2025-12-09 | Bausch Health Companies Inc.Unternehmen | -26,50M | 0,00 | Other Disposition | - | 310,45M | -7,86% |
| 2025-04-02 | Bausch Health Companies Inc.Unternehmen | -10,12M | 0,00 | Other Disposition | - | 310,45M | -3,16% |
| 2025-08-05 | Mr. Brenton L. SaundersCEO & Chairman | -4,23k | 61,10k | Sale to Issuer | 14,44 | 399,98k | -1,05% |
| 2025-07-25 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -2,84k | 40,68k | Sale to Issuer | 14,32 | 71,63k | -3,82% |
| 2025-07-25 | Mr. Luc BonnefoyPresident of Surgical | -2,17k | 31,03k | Sale to Issuer | 14,32 | 28,77k | -7,00% |
| 2025-07-25 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -1,09k | 15,61k | Sale to Issuer | 14,32 | 36,99k | -2,86% |
| 2025-07-25 | Mr. Osama A. EldessoukyExec. VP & CFO | -4,00k | 57,22k | Sale to Issuer | 14,32 | 171,11k | -2,28% |
| 2025-06-13 | Mr. Luc BonnefoyPresident of Surgical | -968,00 | 11,94k | Sale to Issuer | 12,33 | 30,94k | -3,03% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
